3-(carbamoylamino)-5-(3-fluorophenyl)-N-(3-piperidyl)thiophene-2-carboxamide

⇄

cyclin dependent kinase inhibitor 1A ; Homo sapiens







1 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 25349305 Combined CDKN1A/TP53 mutation in bladder cancer is a therapeutic target. 2015 Jan 1